[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335165-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335165-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","unveiling-the-enigmatic-role-of-myh9-in-tumor-biology-a-comprehensive-review","Unveiling the enigmatic role of MYH9 in tumor biology - a comprehensive review","","Non-muscle myosin heavy chain IIA (MYH9), a cytoplasmic motor protein, is widely expressed and couples actin ATP hydrolysis to mechanical motion that supports adhesion, migration, movement, and signaling. Genetic MYH9 alterations underlie autosomal dominant platelet and kidney disorders. Over the past decade, research links MYH9 to tumor initiation and progression, including context-dependent anticancer effects, regulation of T cell function, and its role as a hub in oncogenic signal transduction. The review summarizes therapeutic strategies targeting MYH9 and remaining challenges.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/unveiling-the-enigmatic-role-of-myh9-in-tumor-biology-a-comprehensive-review/335165/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/unveiling-the-enigmatic-role-of-myh9-in-tumor-biology-a-comprehensive-review/335165.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological functions does MYH9 perform according to the document?","Question",{"text":63,"@type":64},"MYH9 interacts with actin to hydrolyze ATP and convert chemical energy into mechanical motion. It also contributes to cell adhesion, migration, movement, and signal transduction, and supports maintenance of signal transduction and cellular morphology.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is MYH9 linked to cancer development and progression?",{"text":68,"@type":64},"Research described in the document indicates that MYH9 expression correlates with metastasis and recurrence across multiple cancer types, and in acute myeloid leukemia it can function as a prognostic indicator.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic strategies targeting MYH9 are discussed, and what challenges remain?",{"text":72,"@type":64},"The document summarizes current therapeutic strategies aimed at MYH9 because it is a key hub in oncogenic signaling. It also highlights that regulatory mechanisms of MYH9-related signaling pathways and their roles in cancer are not fully elucidated, implying ongoing challenges.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335165,1790257492,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Li etal. Cell Communication and Signaling (2024) 22:417  \n[https://doi.org/10.1186/s12964-024-01781-w](https://doi.org/10.1186/s12964-024-01781-w)  \nCell Communication and Signaling  \nREVIEW Open Access  \nUnveiling the enigmatic role of MYH9 in tumor biology: a comprehensive review  \nYunkuo Li 1, Yujie Pan 1, Xiangzhe Yang2, Yuxiong Wang 1, Bin Liu 1, Yanghe Zhang2, Xin Gao 1, Yishu Wang2, Honglan Zhou 1 and Faping Li 1*  \nAbstract  \nNon-muscle myosin heavy chain IIA (MYH9), a member of the non-muscle myosin II (NM II) family, is widely expressed in cells. The interaction of MYH9 with actin in the cytoplasm can hydrolyze ATP, completing the conversion of chemical energy to mechanical motion. MYH9 participates in various cellular processes, such as cell adhesion, migration, movement, and even signal transduction. Mutations in MYH9 are often associated with autosomal dominant platelet disorders and kidney diseases. Over the past decade, tumor-related research has gradually revealed a close relationship between MYH9 and the occurrence and development of tumors. This article provides a review of the research progress on the role of MYH9 in cancer regulation. We also discussed the anticancer effects of MYH9 under special circumstances, as well as its regulation of T cell function. In addition, given the importance of MYH9 as a key hub in oncogenic signal transduction, we summarize the current therapeutic strategies targeting MYH9 as well as the ongoing challenges.  \nKeywords MYH9, Cancer, Signaling pathway, Anticancer therapy  \nIntroduction  \nCancer is a leading cause of death worldwide. About one in six women and one in five men develop cancer in their lifetime. In 2018, 9.6 million people died of cancer [1]. Traditional treatments, including surgery, radiotherapy and chemotherapy, serve as the cornerstone of cancer treatment. In contrast, targeted therapy, immunotherapy and gene therapy are emerging cancer treatments that possess high specificity, fewer side effects and long-term effectiveness [2, 3].  \nNon-muscle myosin heavy chain IIA (MYH9), also known as NMMHC-IIA, is a ubiquitously expressed cytoplasmic myosin, encoded by the MYH9 gene. MYH9 was initially discovered because of platelet disorders  \n*Correspondence: Faping Li[lfping@jlu.edu.cn](lfping@jlu.edu.cn)  \nFull list of author information is available at the end of the article  \ncaused by mutations in the MYH9 gene, and MYH9-related platelet disorder is a common autosomal dominant inherited disease [4]. MYH9, functions as an intracellular molecular motor that interacts with actin and plays a pivotal role in the generation of chemomechanical forces within the cell and the subsequent reorganization of the actin cytoskeleton. It is indispensable in maintaining signal transduction and cellular morphology and is closely associated with various cellular biological processes, including cell migration, adhesion, polarization, and cytokinesis [5, 6]. Recently, MYH9 has been a key factor in cancer development and progression. Researchers have observed that high MYH9 expression is strongly associated with the metastasis and recurrence of esophageal, colorectal, non-small cell lung, breast, kidney, and gastric cancers [7–12]. In acute myeloid leukemia, the expression level of MYH9 can even be used asa prognostic indicator. MYH9 expression has also been shown to be associated with the survival rate of patients  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party ","cbCaifSQaqlszjAY","https://ap.wps.com/l/cbCaifSQaqlszjAY","pdf",2895469,15,"English","# Abstract\n# Introduction\n# Structure, function and role of MYH9\n# Therapeutic strategies and challenges","[{\"question\":\"What biological functions does MYH9 perform according to the document?\",\"answer\":\"MYH9 interacts with actin to hydrolyze ATP and convert chemical energy into mechanical motion. It also contributes to cell adhesion, migration, movement, and signal transduction, and supports maintenance of signal transduction and cellular morphology.\"},{\"question\":\"How is MYH9 linked to cancer development and progression?\",\"answer\":\"Research described in the document indicates that MYH9 expression correlates with metastasis and recurrence across multiple cancer types, and in acute myeloid leukemia it can function as a prognostic indicator.\"},{\"question\":\"What therapeutic strategies targeting MYH9 are discussed, and what challenges remain?\",\"answer\":\"The document summarizes current therapeutic strategies aimed at MYH9 because it is a key hub in oncogenic signaling. It also highlights that regulatory mechanisms of MYH9-related signaling pathways and their roles in cancer are not fully elucidated, implying ongoing challenges.\"}]","Unveiling the enigmatic role of MYH9 in tumor biology - a comprehensive review | PDF",1790009860,38]